# DELMAR PHARMACEUTICALS INC (DMPI)

> Institutional ownership reported to the SEC as of Q2 2020, from Form 13F filings. Source: https://holderbook.com/stocks/DMPI/

- Reporting holders: 8
- Reported value: $189.6K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [RENAISSANCE TECHNOLOGIES LLC](https://holderbook.com/funds/1037389-renaissance-technologies-llc/) | $63.0K | 91,110 | 0.0% | 3 |
| [Virtu Financial LLC](https://holderbook.com/funds/1533964-virtu-financial-llc/) | $47.0K | 68,359 | 0.0% | 2 |
| [BARCLAYS PLC](https://holderbook.com/funds/312069-barclays-plc/) | $25.0K | 36,500 | 0.0% | 3 |
| [BREWIN DOLPHIN LTD](https://holderbook.com/funds/1954243-brewin-dolphin-ltd/) | $20.6K | 30,000 | 0.0% | 3 |
| [CITADEL ADVISORS LLC](https://holderbook.com/funds/1423053-citadel-advisors-llc/) | $16.0K | 23,107 | 0.0% | 1 |
| [NORTHERN TRUST CORP](https://holderbook.com/funds/73124-northern-trust-corp/) | $9.0K | 12,441 | 0.0% | 1 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $6.0K | 8,045 | 0.0% | 1 |
| [ADVISOR GROUP HOLDINGS, INC.](https://holderbook.com/funds/1677044-advisor-group-holdings-inc/) | $3.0K | 4,000 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2020 | 8 | $189.6K |
| Q1 2020 | 5 | $71.9K |
| Q4 2019 | 8 | $337.7K |
| Q3 2019 | 4 | $650.0K |
| Q2 2019 | 4 | $89.0K |
| Q1 2019 | 11 | $391.0K |
| Q4 2018 | 11 | $682.0K |